These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset. MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306 [TBL] [Abstract][Full Text] [Related]
9. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder. Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384 [TBL] [Abstract][Full Text] [Related]
10. Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder. Voronin G; Narasimhan J; Gittens J; Sheedy J; Lipari P; Peters M; DeMarco S; Cao L; Varganov Y; Kim MJ; Pear L; Fotouh E; Sinha S; Ray B; Wu MC; Yalamanchili P; Southgate C; Pick J; Saadipour K; Jung S; Lee J; Mollin A; Welch EM; Wu Z; Weetall M Mol Ther; 2024 Oct; 32(10):3331-3345. PubMed ID: 39033321 [TBL] [Abstract][Full Text] [Related]
11. CDKL5 deficiency disorder in males: Five new variants and review of the literature. Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939 [TBL] [Abstract][Full Text] [Related]
12. Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy. Sun X; Wang T Eur J Pediatr; 2023 Jul; 182(7):3049-3056. PubMed ID: 37166538 [TBL] [Abstract][Full Text] [Related]
13. Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder. Van Bergen NJ; Massey S; Stait T; Ellery M; Reljić B; Formosa LE; Quigley A; Dottori M; Thorburn D; Stroud DA; Christodoulou J Neurobiol Dis; 2021 Jul; 155():105370. PubMed ID: 33905871 [TBL] [Abstract][Full Text] [Related]
14. Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons. Loi M; Trazzi S; Fuchs C; Galvani G; Medici G; Gennaccaro L; Tassinari M; Ciani E Mol Neurobiol; 2020 May; 57(5):2244-2262. PubMed ID: 32002787 [TBL] [Abstract][Full Text] [Related]
15. AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder. Yennawar M; White RS; Jensen FE J Neurosci; 2019 Jun; 39(24):4814-4828. PubMed ID: 30952813 [TBL] [Abstract][Full Text] [Related]
16. First report of Tunisian patients with CDKL5-related encephalopathy. Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975 [TBL] [Abstract][Full Text] [Related]
18. Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder. Leonard H; Junaid M; Wong K; Demarest S; Downs J Epilepsy Res; 2021 Jan; 169():106521. PubMed ID: 33341033 [TBL] [Abstract][Full Text] [Related]